Pfizer Delivers Strong Second-Quarter 2024 Financial Results and Raises 2024 Guidance

Pfizer delivered strong financial results in the second quarter of 2024, driven by the company’s continued focus on commercial execution and solid execution of its strategic priorities for the year. Read more

We Invest in Changing Lives

Welcome to our shareholder community. Here you will find updates on our innovation pipeline progress, performance results, and corporate milestones. You’ll also have the opportunity to hear from our management team. Sign up now for Pfizer Investor Insights to receive information about the company and your investment.

Celebrating 175 Years of Changing Lives at Pfizer

Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart with the driving ambition to discover innovations that help people. Over the past 175 years, we have achieved that and so much more. Read More

Investors, Submit Your Question to Pfizer

We want to hear from you to help ensure that we are providing content that is informative and relevant.

Submit a question here about Pfizer’s R&D pipeline, Pfizer’s capital allocation objectives, or Pfizer’s roadmap for the future.

In the coming weeks and months, we’ll compile answers to common questions, giving you a way to hear from management on topics of interest to you.

Pfizer continues to advance groundbreaking work across all our therapeutics areas while delivering strong results in our innovative R&D pipeline and returning value to shareholders through dividends.

Albert Bourla

Chairman and CEO